Showing results (291-300 of 495) with videos related to
Sort By:
Pageof 50
International Journal of Radiation Oncology, Biology, Physics|June 14, 2002
Intravaginal high-dose-rate brachytherapy for Stage IB (FIGO Grade 1, 2) endometrial cancerKaled M Alektiar, Andrea McKee, Ennapadam Venkatraman, et al.Journal of the National Cancer Institute. Monographs|January 1, 1993
Intraperitoneal administration of Taxol in the management of ovarian cancerM Markman, E Rowinsky, T Hakes, et al.Journal of Managed Care & Specialty Pharmacy|March 28, 2025
Transforming retinal disease management through diabetes careCatherine M Lockhart, Mark R Barakat, Jeffrey D Dunn, et al.Clinical Ophthalmology (Auckland, N.Z.)|February 11, 2025
Human Factors Studies to Assess the Usability of the Faricimab Prefilled SyringeMark R Barakat, Henry M Kwong, Gelson Marcon, et al.Ophthalmology Science|September 27, 2024
Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation TrialMark R Barakat, David Brown, Allen Hu, et al.Gynecologic Oncology|December 7, 2002
Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcomaMario M Leitao, Murray F Brennan, Martee Hensley, et al.Gynecologic Oncology|July 29, 2008
What is the incidence of isolated paraaortic nodal recurrence in grade 1 endometrial carcinoma?Nadeem R Abu-Rustum, Dennis S Chi, Mario Leitao, et al.Gynecologic Oncology|May 1, 1993
Salvage intraperitoneal mitoxantrone therapy of ovarian cancer: influence of increasing the volume of treatmentM Markman, T Hakes, B Reichman, et al.Cancer|February 15, 1993
Intraperitoneal chemotherapy in the management of ovarian cancerM Markman, B Reichman, T Hakes, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1993
Diethyldithiocarbamate chemoprotection of carboplatin--induced hematological toxicityP Francis, M Markman, T Hakes, et al.Pageof 50